SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edward Boghosian who wrote (1607)7/9/1999 8:52:00 PM
From: arnie h  Read Replies (1) of 2173
 
Hi Ed:
<Dare we dream that AMLN will eventually hit around 15 some day.>
Sure! Why not? What it will take is statistically significant and positive results from the Phase 3 trials. There's at least a reasonable shot at this or the Company wouldn't have been able to raise the money they did to keep the outfit going. If you recall, this was done after an extensive review of the earlier trials.

In a much earlier post, I noted that improved glucose control coupled with weight loss and a better HDL/LDL ratio seemed like pretty good therapy. The new candidate adds further value as does the larger tax loss carry forward than reflected in the earlier prices to which you referred.

Time will tell.

Arnie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News